Embecta Profit Margin 2021-2025 | EMBC

Current and historical gross margin, operating margin and net profit margin for Embecta (EMBC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Embecta net profit margin as of March 31, 2025 is 4.89%.
Embecta Annual Profit Margins
Embecta Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Services $0.597B $1.123B
Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.323B 26.51
CVS Health (CVS) United States $85.490B 10.63
Elevance Health (ELV) United States $85.046B 10.97
Cencora (COR) United States $57.007B 19.83
Natera (NTRA) United States $23.468B 0.00
DiDi Global (DIDIY) China $23.015B 24.45
Labcorp Holdings (LH) United States $21.974B 17.82
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.262B 0.00
Solventum (SOLV) United States $12.973B 13.73
CochLear (CHEOY) Australia $12.633B 0.00
ICON (ICLR) Ireland $11.996B 11.15
Revvity (RVTY) United States $11.361B 19.55
Viatris (VTRS) United States $10.504B 3.61
Avantor (AVTR) United States $9.172B 13.33
Medpace Holdings (MEDP) United States $9.062B 24.07
HealthEquity (HQY) United States $9.009B 39.46
Sonic Healthcare (SKHHY) Australia $8.263B 0.00
Charles River Laboratories (CRL) United States $7.289B 14.28
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.259B 25.08
BrightSpring Health Services (BTSG) United States $4.024B 36.92
Sotera Health (SHC) United States $3.191B 18.13
Alignment Healthcare (ALHC) United States $2.786B 0.00
Concentras Parent (CON) United States $2.716B 15.70
Surgery Partners (SGRY) United States $2.705B 35.18
GeneDx Holdings (WGS) United States $2.594B 99.89
Organon (OGN) United States $2.587B 2.75
PACS (PACS) United States $1.928B 0.00
Ardent Health (ARDT) United States $1.887B 8.04
Progyny (PGNY) United States $1.822B 40.11
GoodRx Holdings (GDRX) United States $1.811B 36.21
Premier (PINC) United States $1.791B 13.59
Teladoc Health (TDOC) United States $1.403B 0.00
Pediatrix Medical (MD) United States $1.158B 8.81
CareDx (CDNA) United States $1.051B 16.42
Establishment Labs Holdings (ESTA) $1.034B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.915B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.831B 7.78
Nutex Health (NUTX) United States $0.641B 9.70
LifeMD (LFMD) United States $0.639B 0.00
InnovAge Holding (INNV) United States $0.545B 0.00
Enhabit (EHAB) United States $0.482B 39.62
Sonida Senior Living (SNDA) United States $0.463B 0.00
Auna S.A (AUNA) Luxembourg $0.463B 10.42
SBC Medicals (SBC) United States $0.442B 0.00
Omada Health (OMDA) $0.404B 0.00
Performant Healthcare (PHLT) United States $0.298B 0.00
Beauty Health (SKIN) United States $0.242B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.237B 0.00
Oncology Institute (TOI) United States $0.210B 0.00
DocGo (DCGO) United States $0.176B 28.83
So-Young (SY) China $0.174B 0.00
Pheton Holdings (PTHL) China $0.123B 0.00
OncoCyte (IMDX) United States $0.099B 0.00
KindlyMD (NAKA) United States $0.092B 0.00
Sera Prognostics (SERA) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00